| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9957169 | International Journal of Cardiology | 2005 | 5 Pages |
Abstract
Bosentan was safe and well tolerated in adults with Eisenmenger physiology both at initiation and after 3 months of oral therapy. Clinical status of patients and pulmonary haemodynamics appeared to improve, and this warrants further investigation.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Michael A. Gatzoulis, Paula Rogers, Wei Li, Carl Harries, Derek Cramer, Simon Ward, Ghada W. Mikhail, J. Simon R. Gibbs,